To determine whether the graded severity of smoke inhalation is reflected by the acute pulmonary inflammatory response to injury.
I n the United States, 40,000 hospital admissions for burn injury occur each year (1) . Approximately 6%-20% of fire victims have a concurrent inhalation injury, which is a chemical insult rather than a thermal tracheobronchiolitis (2, 3) . Acutely, those with an inhalation injury have more pronounced arterial hypotension and require more extensive fluid resuscitation, and the diffuse epithelial sloughing, bronchorrhea, and plugging of subsegmental bronchi characteristic of inhalation injury can result in subsequent pneumonia rates of 20%-50% (4) (5) (6) (7) (8) . Furthermore, the combination of pulmonary and dermal injury may double a patient's mortality (8) . Previous investigations in patients with smoke inhalation have revealed a temporal increase in proinflammatory cytokine levels in the airway (9) , coupled with alveolar leukocytes that are "primed" for an enhanced response to stimulation with lipopolysaccharide (10) . However, these early studies did not examine inflammatory mediators in the context of severity of inhalation injury. As such, we hypothesized that proinflammatory mediators at the alveolar level would increase as the degree of inhalation injury increased, highlighting the impor-tance of classifying inhalation injury as a graded phenomenon.
MATERIALS AND METHODS
From January 2007 to April 2010, bronchoalveolar lavage fluid (BALF) was collected from 60 patients admitted to the Burn Intensive Care Unit in whom inhalation injury was suspected by history and/or physical findings, such as injury within a confined space or soot at the nares or tracheal secretions. Patients were excluded from the study for the following: age younger than 18 yrs; malignancy; immunosuppressive medications; or known autoimmune or chronic inflammatory diseases. Clinical variables and outcomes collected were: age; gender; race/ ethnicity; percent total body surface area (TBSA) burn; inhalation injury grade; partial pressure of oxygen in arterial blood-tofraction of inspired oxygen ratio at the time of bronchoscopy; initial 24-hr and 72-hr fluid requirements; incidence of pneumonia; incidence of sepsis; intensive care unit and hospital length of stay; and mortality. Pneumonia was defined as any bronchoalveolar lavage (BAL) culture of .100,000 colony-forming units, and sepsis defined as hemodynamic instability in combination with a documented source of infection (blood, urine, BAL, or wound). All samples were collected before any aerosolized pulmonary medications had been administered. Six nonsmoking, nonintubated, nonhospitalized healthy adult volunteers (free from pulmonary, cardiac, infectious, and allergic disease) were also included as a control group for comparison. This study was approved by the Loyola University Medical Center Institutional Review Board.
Inhalation Injury Scoring System. The degree of inhalation injury was determined using a standardized bronchoscopic scoring system based on Abbreviated Injury Score criteria, as we have previously published (11) . The severity of inhalation injury was graded into five categories (0, 1, 2, 3, and 4), with 0 being the absence of visible inhalation injury (Table 1) .
Bronchoalveolar Lavage. Bronchoscopy and BAL were performed by a standardized protocol within 14 hrs in all burn-injured patients (12) . That which was not required for routine clinical analysis was pooled for research use. In control subjects, the bronchoscope was directed into a subsegment of the right middle lobe and wedged; the first 50 mL aliquot of saline was instilled and the aspirate was discarded. Subsequent 50-mL aliquots were instilled into the same subsegment and immediately aspirated with gentle hand aspiration into sterile syringes. These were immediately transferred into sterile 50-mL conical tubes, placed on ice, and transported to the laboratory for additional processing. There were no immediate complications to bronchoscopy in either the patient group or the control group.
Sample Processing. BALF samples were strained through sterile 100-micron nylon cell strainers (BD Biosciences, Bedford, MA). The raw sample was centrifuged at 1200 rpm for 5 mins to separate the supernatant from the cellular component. The supernatant was then aliquoted and frozen at -80°C. Cytokine concentrations in BALF were measured by Bio-Rad Multiplex Assays (Hercules, CA) according to manufacturer protocol. All samples were assayed in duplicate and the results were analyzed using the Bio-Plex manager software (version 5.0) (Bio-Rad Laboratories).
Statistical Analysis. Patient demographics, outcomes, and inflammatory mediator concentrations were assessed for normality and parametric or nonparametric tests applied when appropriate. Correlations were performed with Spearman rank correlation coefficient and the r value was reported. Continuous variables of parametric tests are reported as mean with sd, and those of nonparametric tests were reported as median with 25 th and 75 th percentiles. Otherwise dichotomous variables are reported as a number and percent. Statistical analyses were calculated with SAS version 9.1 (SAS Institute, Cary, NC) and corresponding graphs created with GraphPad Prism 5 for Windows (GraphPad Software, La Jolla, CA). A difference between observed variables was considered statistically significant when p , .05.
RESULTS

Patient Characteristics by Inhalation Injury Grade
As shown in Table 2 , patients with each grade of inhalation injury were similar in terms of age, gender, race/ ethnicity, and percent TBSA burn across grades of inhalation injury. The percent of plasma carboxyhemoglobin (COHb) measured nearest the time of injury was predictably higher among patients with higher grades of inhalation injury. Likewise, the BALF white blood cell distribution changed across grades of inhalation injury, with a significant shift from a macrophage-predominant population to one dominated by neutrophils. Although the initial partial pressure of oxygen in arterial blood-to-fraction of inspired oxygen ratio was lower in those with a grade 4 injury, no significant difference was reached.
Patient Outcomes by Inhalation Injury Grade
As shown in Table 3 , the degree of inhalation injury did not have a significant effect on subsequent pneumonia, sepsis, hospital length of stay, or mortality, nor did it appear to be a risk factor for mortality when adjusting for the effects of age and percent TBSA. However, those with a more severe inhalation injury required greater ventilator days and a trend toward a greater rate of tracheostomy and intensive care unit length of stay. When comparing those without inhalation injury (grade 0) to those with any inhalation injury as a single group (grades 1-4), initial 24-hr fluid requirements were greater (median, 4.2 L vs. 8.8 L, respectively; p 5 .036), as were the number of ventilator days (median, 3 vs. 15; p , .001) and tracheostomies (0 vs. 51%; p 5 .021).
Inflammatory Mediators by Inhalation Injury Grade
Inflammatory mediators with statistical significance and/or the potential for biological relevance are shown in Figure 1 . Across grades of inhalation injury (and excluding controls for statistical comparison), the overall median value differed significantly (p , .05) for complement component 5a, interleukin (IL)-6, IL-15, interferon-, monocyte chemotactic protein-1, regulated on activation normal T-expressed and secreted, tumor necrosis factor-, and vascular endothelial growth factor. IL-7 and platelet-derived growth factor were not graphically represented, although they had similar differences between medians (p , .05). Of all the mediators tested, only vascular endothelial growth factor demonstrated a pattern of decreasing concentrations across the grades of inhalation injury. No protein demonstrated a linear relationship to the grade of inhalation injury.
Patient Characteristics When Grouped by Inhalation Injury Severity
To minimize clinician bias during inhalation injury grading, and to better assess the effects of inhalation injury severity, patients were grouped and compared according to low inhalation injury severity (grades 1 and 2) and high inhalation Table 4 . Most importantly, there were no differences in age, gender, race/ethnicity, and percent TBSA; furthermore, the groups did not differ by initial partial pressure of oxygen in arterial blood to fraction of inspired oxygen ratio, BALF white blood cell differential, or initial BALF culture for microorganisms. On the contrary, those with a high inhalation injury compared to low inhalation injury severity appeared to have a greater percent COHb (median, 10.4% vs. 5.1%), although this difference only approached statistical significance (p 5 .059). Table 5 demonstrates the comparison of BAL fluid immune mediator concentrations not only of those with low and high inhalation injury severities but also of subjects without visible inhalation injury (grade 0) and controls. Compared to controls, IL-1RA, IL-7, IL-8, IL-10, and macrophage inflammatory protein-1 were elevated in grade 0 patients, whereas the concentration of granulocyte macrophage colony-stimulating factor was lower. With the addition of inhalation injuries, IL-1, IL-1RA, IL-6, IL-8, IL-9, granulocyte-colony stimulating factor interferon-, monocyte chemotactic protein-1, MIP-1, plateletderived growth factor, and regulated on activation normal T-expressed and secreted were increased over controls and/or grade 0 patients, whereas IL-7 and vascular endothelial growth factor tended to be lower.
Patient Outcomes When Grouped by Inhalation Injury Severity
As with worsening inhalation injury grades, the group with the highest inhalation injury severity required significantly more ventilator days (p 5 .036) and intensive care unit days (p 5 .040) compared to those with a more mild inhalation injury severity (Table 6 ). Although the severity of inhalation injury had no effect on either the resuscitation fluid requirements or mortality, patients with the worst inhalation injury severity also tended to have a greater percentage who required a tracheostomy (33% vs. 52%), percentage who had pneumonia or sepsis develop (43% vs. 67% and 13% vs. 29%), and a longer hospital length of stay (11 vs. 25 days).
Inflammatory Mediators When Grouped by Inhalation Injury Severity
In contrast to the comparison of patient characteristics, numerous differences Data presented as n (%), median (interquartile range), or mean (6sem), where appropriate. were found between the inflammatory mediator profile of those with low vs. high inhalation injury severities (Fig. 2 
Correlations With Presenting Characteristics and Outcomes
Given that carbon monoxide has known immune modulating effects (namely anti-inflammatory), we assessed for a correlation between the initial percent carboxyhemoglobin and BALF immune mediator concentrations. We found differences that were only suggestive of significance (p , .10) between percent COHb and the BALF concentrations of complement component 5a, IL-1, IL-8, fibroblast growth factor-basic, interferon-, monocyte chemotactic protein-1, MIP-1, and platelet-derived growth factor. Furthermore, the percent COHb did not correlate with initial partial pressure of oxygen in arterial blood-to-fraction of inspired oxygen ratio (r 5 -0.184; p 5 .187).
Correlations with outcomes were also assessed for inhalation injury tgrade, percent TBSA, and the concentration of 13 immune mediators measured in the BALF selected for either concentrations found at physiologically relevant levels or those that have been previously studied in burn care ( Table 7) . Inhalation injury grade correlated with frequency of tracheostomy, number of ventilator days, intensive care unit length of stay, hospital length of stay (p , .05 for all), and nearly the frequency of pneumonia (p 5 .051). Likewise, percent TBSA correlated with fluid resuscitation requirements, pneumonia, ventilator days, intensive care unit length of stay, hospital length of stay, and mortality (p , .05 for all). No BALF mediator concentration correlated with resuscitation requirements. However, we did find the following differences: IL-1 correlated with sepsis and intensive care unit length of stay and inversely with mortality; IL-1RA correlated with sepsis and inversely with mortality; IL-8 correlated inversely with mortality; IL-10 correlated inversely with mortality; granulocyte-colony stimulating factor correlated inversely Data presented as n (%), median (interquartile range), or mean (6sem), when appropriate. with mortality; monocyte chemotactic protein-1 correlated with the frequency of tracheostomy; regulated on activation normal T-expressed and secreted correlated with the frequency of tracheostomy; and tumor necrosis factor- correlated with intensive care unit length of stay (p , .05 for all).
DISCUSSION
It is well-established that patients with smoke inhalation injury in addition to (29) .177 Intensive care unit length of stay 13 (6-37) 24 .040 Hospital length of stay 11 25 .081 Mortality 9 (30) 4 (19) .626
Data presented as n (%) or median (interquartile range), when appropriate. dermal injury have poorer outcomes than those with skin burns alone (4-8, 13, 14) . Animal experiments suggest that these effects are modulated by an augmented inflammatory response (15) (16) (17) (18) and, in humans, smoke inhalation injury seems to evoke enhanced pulmonary leukocyte activity and pronounced alveolar neutrophilia (9, 10) . Although these initial reports focused on the early time course of the pulmonary inflammatory response to inhalation injury, none addressed the magnitude of inflammatory response as it relates to the degree of inhalation injury. The present study of human burn victims not only reaffirms the effects of smoke inhalation on many burn patient outcomes but also is the first to demonstrate that the severity of inhalation injury may play a role in the overall pulmonary inflammatory response. One such feature of the burn patient with smoke inhalation that we have redemonstrated is the association of elevated COHb levels in patients with higher grades of inhalation injury. In addition to the potential for cerebrotoxicity, carbon monoxide has been shown in a large animal model of combined burn and smoke inhalation injury to be associated with an increased pulmonary shunt fraction (18, 19) . Although this feature could have profound effects on the burned patient through hypoxemic pulmonary vasoconstriction and ventilation/perfusion mismatching, we failed to note any substantial differences in the initial partial pressure of oxygen in arterial blood-to-fraction of inspired oxygen ratio over the range of inhalation injury severities. Furthermore, the anti-inflammatory effects of carbon monoxide have been previously noted in the setting of burn and smoke inhalation injury, sepsis, and trauma (20) (21) (22) (23) (24) . One might theorize that carbon monoxide, if present at higher levels in patients with greater inhalation injury severities, would mute the inflammatory response to worsening injury. That we still see a greater immune response with worse grades of inhalation injury suggests a limited effect of carbon monoxide on reducing the pulmonary inflammatory response in these patients.
Another finding of our study was a shift in the BALF white blood cell differential to one of neutrophil predominance, confirming earlier findings observed in smoke inhalation by Wright and Murphy and by Riyami et al (10, 25) . In fact, in patients with a grade 4 inhalation injury, 94% of the leukocyte population was neutrophils. This contrasts sharply with the normal pulmonary leukocyte distribution, which is upwards of 95% macrophages (26) . In light of previous studies on burn and inhalation injury, we speculate that a robust production of chemotactic factors (such as IL-8), in addition to the extensive and narrow pulmonary vascular bed, are contributory to this phenomenon (9, 27, 28) . Regardless of the mechanism, the preponderance of neutrophils might contribute to later immune dysfunction, bacterial overgrowth, and pneumonia (14, 29) . Although differences in many initial patient characteristics fell short of statistical significance when contrasting low and high severities of inhalation injury, certain outcomes across inhalation injury grades persisted with this method of comparison. For instance, the requirement for tracheostomy, the number of ventilator days, and the intensive care unit length of stay tended to be increased with worse grades of inhalation injury. Likewise, when placing emphasis on the difference between inhalation injury severities, those with the worst injuries had more tracheostomies, ventilator days, pneumonia, sepsis, days in the intensive care unit, and overall hospital length of stay. Perhaps of greatest importance is that patients in our study with an inhalation injury of any kind had a mortality of 27% as compared to only 11% for those without, which is similar to findings by Shirani et al in 1987 (30) , who also showed that inhalation injury in addition to burns increased mortality by approximately 20%. Finally, the inverse correlation of numerous pulmonary immune mediator concentrations with mortality deserves mention. On close inspection of these patients, Davis et al (31) found not only that many BALF immune mediator concentrations were lower in those who would die from their injuries but also that pulmonary leukocyte production of these mediators in culture, particularly after stimulation with lipopolysaccharide, was blunted.
Although many of our results substantiate already held tenets of burn and inhalation injury, our having demonstrated an enhanced pulmonary inflammatory response to worse degrees of inhalation injury is a new contribution. Previous studies directed at delineating the alveolar response to inhalation injury have shown that leukocytes recruited to the alveolar space have been primed for further stimulus, and that alterations of the inflammatory mediator profile of the lung may correlate with pulmonary physiologic dysfunction and later pneumonia (9, 27) . Our results indicate that many inflammatory mediators present in the BALF of those with an inhalation injury are significantly altered, even as early as within 14 hrs of injury. Of these, we have identified IL-1, IL-1RA, IL-6, IL-8, and interferon- as best representing physiologically relevant levels and among the most important in regard to lung injury. Each of these immune mediators has been extensively studied in humans and in animal models of burn injury, lending further credibility for their importance and potential for therapeutic intervention (10, (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) .
We concede that our study has certain limitations. First, there is an inherent selection bias in that only those suspected of an inhalation injury were candidates for enrollment. Therefore, much of the burn patient population outside of this category were not included for comparison, which may or may not have had significant effects on specific findings, those in particular being resuscitative fluid requirements and mortality. Second, the precision of BALF for measuring pulmonary inflammatory mediators is subject not only to various degrees of dilution but also to iatrogenic trauma to the airway, which may result in contamination from blood and other cellular debris. Furthermore, at present, there is no standard denominator to correct for these possible confounders. Nonetheless, adjustment for total protein content in the BAL fluid had little impact on the results of our study and the overall discussion would have remained unchanged. Third, we were unable to account for the possibility that aspiration of oral, pharyngeal, or gastroduodenal contents may have had any effect on the inflammatory response that we observed. Finally, bronchoscopic grading of inhalation injury grade is inherently subject to inter-rater differences, even though our system is based on Abbreviated Injury Score criteria. To minimize such effects, we also demonstrated our findings according to low and high severities of inhalation injury in a manner that we feel allowed for better clarity of the primary inflammatory response to inhalation injury.
CONCLUSIONS
Our study, emphasizing smoke inhalation injury in the burn-injured patient, demonstrates several correlates with worse grades of inhalation injury. Specifically, we have found that worse inhalation injury is associated with a greater degree of alveolar neutrophilia, elevated plasma COHb levels, a greater likelihood of tracheostomy, prolonged ventilator requirements, longer length of stay in both the intensive care unit and the hospital, and enhanced pulmonary inflammatory mediator production. These data, we hope, will serve the purpose of better understanding the biological mechanisms behind smoke inhalation injury, and we believe that future investigations should consider inhalation injury to be a graded phenomenon.
